- Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients
-
Cha DI, Jang KM, Kim SH, Kim YK, Kim H, Ahn SH
- KMID: 2471806
- Korean J Radiol.
- 2020 Apr;21(4):402-412.
- doi: 10.3348/kjr.2019.0538
OBJECTIVE: To evaluate the performance of predicting early recurrence using preoperative factors only in comparison with using both pre-/postoperative factors. MATERIALS AND METHODS: We retrospectively reviewed 549 patients who had undergone... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients
-
Park KH, Kim JH, Choe WH, Kwon SY, Yoo BC, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ
- KMID: 2471898
- Korean J Gastroenterol.
- 2020 Mar;75(3):147-156.
- doi: 10.4166/kjg.2020.75.3.147
BACKGROUND/AIMS: A switch to systemic therapy, such as sorafenib, should be considered for hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization (TACE). On the other hand, treatment changes are difficult... -
- CITED
-
- Close
- SHARE
-
- Close
- Cone-Beam Computed Tomography-Hepatic Arteriography as a Diagnostic Tool for Small Hypervascular Hepatocellular Carcinomas: Method and Clinical Implications
-
Choi YR, Chung JW, Kim JH, Kim HC, Jae HJ, Hur S
- KMID: 2470754
- Korean J Radiol.
- 2020 Mar;21(3):306-315.
- doi: 10.3348/kjr.2019.0060
OBJECTIVE: This study proposes a novel reference standard for hypervascular hepatocellular carcinomas (HCCs), established by cone-beam computed tomography-hepatic arteriography (CBCT-HA) and two-year imaging follow-up, and discusses its clinical implication on... -
- CITED
-
- Close
- SHARE
-
- Close
- Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
-
Park SH, Kim B, Kim SY, Choi SJ, Huh J, Kim HJ, Kim KW, Lee SS
- KMID: 2470751
- Korean J Radiol.
- 2020 Mar;21(3):280-289.
- doi: 10.3348/kjr.2019.0447
OBJECTIVE: To test the feasibility of non-contrast magnetic resonance imaging (MRI) in a sequential imaging study for characterizing computed tomography (CT)-detected arterial-enhancing nodules that do not washout in patients at... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma metastasis to the buccal mucosa masquerading as oral cavity malignancy: Case report of a rare entity
-
Nadkarni S, Patkar S, Acharya R, Shah A, Patel S, Parray A, Goel M
- KMID: 2471192
- Ann Hepatobiliary Pancreat Surg.
- 2020 Feb;24(1):68-71.
- doi: 10.14701/ahbps.2020.24.1.68
Hepatocellular carcinoma, a disease of the developing world, is known to present with extrahepatic metastases. Most common site being the lungs, it is not uncommon for metastases to present at... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcome of intraoperative radiofrequency ablation for hepatocellular carcinoma and its efficacy as a primary treatment
-
Kwon J, Chun KS, Song IS, Kim SH, Han S
- KMID: 2471185
- Ann Hepatobiliary Pancreat Surg.
- 2020 Feb;24(1):24-32.
- doi: 10.14701/ahbps.2020.24.1.24
BACKGROUNDS/AIMS: We conducted this study to identify long-term outcomes following intraoperative radiofrequency ablation (IO-RFA) for hepatocellular carcinoma (HCC) and to reveal independent prognostic factors for survival. METHODS: From December 1998 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
-
Lee HW, Cho KJ, Park JY
- KMID: 2471051
- Immune Netw.
- 2020 Feb;20(1):e11.
- doi: 10.4110/in.2020.20.e11
Most patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage of disease. Until recently, systemic treatment options that showed survival benefits in HCC have been limited to tyrosine... -
- CITED
-
- Close
- SHARE
-
- Close
- What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma?
-
Navarro JG, Yang SJ, Kang I, Choi GH, Han DH, Kim KS, Choi JS
- KMID: 2469105
- Ann Surg Treat Res.
- 2020 Feb;98(2):62-71.
- doi: 10.4174/astr.2020.98.2.62
PURPOSE: The risk of posthepatectomy liver failure (PHLF) after right hepatectomy remains substantial. Additional parameters such as computed tomography volumetry, liver stiffness measurement by FibroScan, indocyanine green retention rate at... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study
-
Jang HJ, Yang HR, Ko JS, Moon JS, Chang JY, Seo JK
- KMID: 2466582
- J Korean Med Sci.
- 2020 Jan;35(1):e5.
- doi: 10.3346/jkms.2020.35.e5
BACKGROUND: Glycogen storage disease (GSD) is an inherited disorder leading to abnormal glucose metabolism and glycogen accumulation, and is associated with various complications including hepatic adenoma and hepatocellular carcinoma. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Unplanned conversion during minimally invasive liver resection for hepatocellular carcinoma: risk factors and surgical outcomes
-
Lee JY, Rho SY, Han DH, Choi JS, Choi GH
- KMID: 2466560
- Ann Surg Treat Res.
- 2020 Jan;98(1):23-30.
- doi: 10.4174/astr.2020.98.1.23
PURPOSE: Unplanned conversion is sometimes necessary during minimally invasive liver resection (MILR) of hepatocellular carcinoma (HCC). The aims of this study were to compare surgical outcomes of planned MILR and... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors prognostic of ruptured hepatocellular carcinoma presenting to the emergency department
-
Lee SH, Kim JS, Yu GN, Kim YJ, Ryoo SM, Sohn CH, Kim WY, Ahn S
- KMID: 2470542
- J Korean Soc Emerg Med.
- 2019 Dec;30(6):521-528.
- doi: 10.0000/jksem.2019.30.6.521
OBJECTIVE: This study assessed whether characteristics of ruptured hepatocellular carcinoma (HCC) at presentation to the emergency department (ED) affect patient outcomes, and evaluated factors prognostic of HCC, particularly treatment modalities. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy for mandibular metastases from hepatocellular carcinoma: a single institutional experience
-
Park J, Yoon SM
- KMID: 2468738
- Radiat Oncol J.
- 2019 Dec;37(4):286-292.
- doi: 10.3857/roj.2019.00479
PURPOSE: A mandibular metastasis is uncommon in patients with hepatocellular carcinoma (HCC). We report the clinical features of this rare lesion and evaluate the effectiveness of radiotherapy in affected patients. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- Noninvasive Biomarker for Predicting Treatment Response to Concurrent Chemoradiotherapy in Patients with Hepatocellular Carcinoma
-
Chung YE, Park JY, Choi JY, Kim MJ, Park MS, Seong J
- KMID: 2468052
- Investig Magn Reson Imaging.
- 2019 Dec;23(4):351-360.
- doi: 10.13104/imri.2019.23.4.351
PURPOSE: To investigate noninvasive biomarkers for predicting treatment response in patients with locally advanced HCC who underwent concurrent chemoradiotherapy (CCRTx). MATERIALS AND METHODS: Thirty patients (55.5 ± 10.2 years old, M:F... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
-
Shin H, Jung YW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim YY, Choi JY, Kim SU
- KMID: 2467249
- Clin Mol Hepatol.
- 2019 Dec;25(4):390-399.
- doi: 10.3350/cmh.2018.0103
BACKGROUND/AIMS: A risk prediction model for the development of hepatocellular carcinoma (HCC) from indeterminate nodules detected on computed tomography (CT) (Rad(CT) score) in patients with chronic hepatitis B (CHB)-related cirrhosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
-
Moriya K, Namisaki T, Sato S, Furukawa M, Douhara A, Kawaratani H, Kaji K, Shimozato , Sawada Y, Saikawa S, Takaya H, Kitagawa K, Akahane T, Mitoro A, Yamao J, Yoshiji H
- KMID: 2467248
- Clin Mol Hepatol.
- 2019 Dec;25(4):381-389.
- doi: 10.3350/cmh.2019.0037
BACKGROUND AND AIMS: We previously reported the comparable efficacy of bi-monthly hepatic arterial infusion chemotherapy (B-HAIC) to that of sorafenib chemotherapy for the treatment of advanced hepatocellular carcinoma (aHCC) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
-
Ahn KS, Kang KJ
- KMID: 2467244
- Clin Mol Hepatol.
- 2019 Dec;25(4):354-359.
- doi: 10.3350/cmh.2018.0096
There has been controversy regarding the first-line treatment modality for the patients who have small solitary hepatocellular carcinoma (HCC); radiofrequency ablation (RFA) or percutaneous ethanol injection (PEI), surgical hepatic resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
-
Yang JD
- KMID: 2467242
- Clin Mol Hepatol.
- 2019 Dec;25(4):335-343.
- doi: 10.3350/cmh.2019.0010
Very early stage hepatocellular carcinoma (HCC) is defined as a single tumor with the largest diameter of the lesion measuring 2 cm or less according to Barcelona Liver Cancer staging... -
- CITED
-
- Close
- SHARE
-
- Close
- Intraoperative radiofrequency ablation and distilled water peritoneal lavage for spontaneously ruptured hepatocellular carcinoma
-
Kwak BJ, Park J, Kwon YK, Kwon JH, Yoon YC
- KMID: 2464784
- Ann Surg Treat Res.
- 2019 Dec;97(6):291-295.
- doi: 10.4174/astr.2019.97.6.291
PURPOSE: Spontaneously ruptured hepatocellular carcinoma (srHCC) is known to be a life-threatening complication with poor prognosis. Although there are various treatment modalities, there is no definite treatment guideline. The purpose... -
- CITED
-
- Close
- SHARE
-
- Close
- Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis
-
Guo Y, Tan EK, Syn NL, Krishnamoorthy TL, Tan CK, Lim R, Lee SY, Chan CY, Cheow PC, Chung AY, Jeyaraj PR, Goh BK
- KMID: 2464317
- Ann Hepatobiliary Pancreat Surg.
- 2019 Nov;23(4):305-312.
- doi: 10.14701/ahbps.2019.23.4.305
BACKGROUNDS/AIMS: Repeat liver resection (RLR) and salvage liver transplantation (SLT) are viable treatment options for recurrent hepatocellular carcinoma (HCC). With possibly superior survival outcomes than RLR, SLT is however, limited... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center
-
Xu L, Li L, Wang P, Zhang M, Zhang Y, Hao X, Yan L, Li B, Wen T, Xu M
- KMID: 2464314
- Gut Liver.
- 2019 Nov;13(6):669-682.
- doi: 10.5009/gnl18489
BACKGROUND/AIMS: Microvascular invasion (MVI) is an established risk factor for hepatocellular carcinoma (HCC). However, prediction models that specifically focus on the individual prognoses of HCC patients with MVI is lacking. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
